Impacto de la primera línea en el tratamiento de segunda línea: nuevas experiencias - page 20

M Salgado, Madrid 9 de febrero de 2017

Hofheinz R et al. J Clin Oncol 34, 2016 (suppl 4S; abstr 681)

INFLUENCIA DEL TRATAMIENTO ANTI-EGFR PREVIO

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,10,11,12,13,14,15,16,17,18,19 21,22,23,24,25,26,27,28,29,...30